257 related articles for article (PubMed ID: 20006516)
1. Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus.
Zarubaev VV; Golod EL; Anfimov PM; Shtro AA; Saraev VV; Gavrilov AS; Logvinov AV; Kiselev OI
Bioorg Med Chem; 2010 Jan; 18(2):839-48. PubMed ID: 20006516
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2.
Kolocouris N; Kolocouris A; Foscolos GB; Fytas G; Neyts J; Padalko E; Balzarini J; Snoeck R; Andrei G; De Clercq E
J Med Chem; 1996 Aug; 39(17):3307-18. PubMed ID: 8765514
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity.
Zoidis G; Kolocouris N; Naesens L; De Clercq E
Bioorg Med Chem; 2009 Feb; 17(4):1534-41. PubMed ID: 19195900
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of bioactive adamantane spiro heterocycles.
Kolocouris N; Zoidis G; Foscolos GB; Fytas G; Prathalingham SR; Kelly JM; Naesens L; De Clercq E
Bioorg Med Chem Lett; 2007 Aug; 17(15):4358-62. PubMed ID: 17588747
[TBL] [Abstract][Full Text] [Related]
5. Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.
Barr IG; Hurt AC; Iannello P; Tomasov C; Deed N; Komadina N
Antiviral Res; 2007 Feb; 73(2):112-7. PubMed ID: 16963130
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, conformational characteristics and anti-influenza virus A activity of some 2-adamantylsubstituted azacycles.
Setaki D; Tataridis D; Stamatiou G; Kolocouris A; Foscolos GB; Fytas G; Kolocouris N; Padalko E; Neyts J; De Clercq E
Bioorg Chem; 2006 Oct; 34(5):248-73. PubMed ID: 16879857
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines.
Zoidis G; Kolocouris N; Kelly JM; Prathalingam SR; Naesens L; De Clercq E
Eur J Med Chem; 2010 Nov; 45(11):5022-30. PubMed ID: 20805012
[TBL] [Abstract][Full Text] [Related]
8. Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries.
Barr IG; Deng YM; Iannello P; Hurt AC; Komadina N
Antiviral Res; 2008 Nov; 80(2):200-5. PubMed ID: 18611414
[TBL] [Abstract][Full Text] [Related]
9. Influence of an additional 2-amino substituent of the 1-aminoethyl pharmacophore group on the potency of rimantadine against influenza virus A.
Tataridis D; Fytas G; Kolocouris A; Fytas C; Kolocouris N; Foscolos GB; Padalko E; Neyts J; De Clercq E
Bioorg Med Chem Lett; 2007 Feb; 17(3):692-6. PubMed ID: 17113287
[TBL] [Abstract][Full Text] [Related]
10. Heterocyclic rimantadine analogues with antiviral activity.
Zoidis G; Fytas C; Papanastasiou I; Foscolos GB; Fytas G; Padalko E; De Clercq E; Naesens L; Neyts J; Kolocouris N
Bioorg Med Chem; 2006 May; 14(10):3341-8. PubMed ID: 16439137
[TBL] [Abstract][Full Text] [Related]
11. Anti-influenza activity of diazaadamantanes combined with monoterpene moieties.
Suslov E; Zarubaev VV; Slita AV; Ponomarev K; Korchagina D; Ayine-Tora DM; Reynisson J; Volcho K; Salakhutdinov N
Bioorg Med Chem Lett; 2017 Oct; 27(19):4531-4535. PubMed ID: 28886889
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
Jonges M; van der Lubben IM; Dijkstra F; Verhoef L; Koopmans M; Meijer A
Antiviral Res; 2009 Sep; 83(3):290-7. PubMed ID: 19591877
[TBL] [Abstract][Full Text] [Related]
13. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of dihydrofuran-fused perhydrophenanthrenes as a new anti-influenza agent having novel structural characteristic.
Matsuya Y; Sasaki K; Ochiai H; Nemoto H
Bioorg Med Chem; 2007 Jan; 15(1):424-32. PubMed ID: 17035034
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective synthesis of novel adamantane derivatives with high potency against rimantadine-resistant influenza A virus strains.
Kuznetsov NY; Tikhov RM; Godovikov IA; Medvedev MG; Lyssenko KA; Burtseva EI; Kirillova ES; Bubnov YN
Org Biomol Chem; 2017 Apr; 15(15):3152-3157. PubMed ID: 28338150
[TBL] [Abstract][Full Text] [Related]
16. Antiviral compounds. XIII. Synthesis and anti-influenza virus activity of N-(1-adamantyl)amidinohydrazones.
Nishimura T; Toku H; Fukuyasu H; Kawakami M; Kazuno Y; Sekizawa Y
Kitasato Arch Exp Med; 1979 Dec; 52(1-4):15-21. PubMed ID: 261989
[No Abstract] [Full Text] [Related]
17. Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors.
Zhao X; Jie Y; Rosenberg MR; Wan J; Zeng S; Cui W; Xiao Y; Li Z; Tu Z; Casarotto MG; Hu W
Antiviral Res; 2012 Nov; 96(2):91-9. PubMed ID: 22982118
[TBL] [Abstract][Full Text] [Related]
18. Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives.
Yeh JY; Coumar MS; Horng JT; Shiao HY; Kuo FM; Lee HL; Chen IC; Chang CW; Tang WF; Tseng SN; Chen CJ; Shih SR; Hsu JT; Liao CC; Chao YS; Hsieh HP
J Med Chem; 2010 Feb; 53(4):1519-33. PubMed ID: 20092255
[TBL] [Abstract][Full Text] [Related]
19. Effects of polyphenol compounds on influenza A virus replication and definition of their mechanism of action.
Fioravanti R; Celestino I; Costi R; Cuzzucoli Crucitti G; Pescatori L; Mattiello L; Novellino E; Checconi P; Palamara AT; Nencioni L; Di Santo R
Bioorg Med Chem; 2012 Aug; 20(16):5046-52. PubMed ID: 22743086
[TBL] [Abstract][Full Text] [Related]
20. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Jan; 55(2):44-6. PubMed ID: 16424859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
